Galmed Pharmaceuticals Lt... (GLMD)
NASDAQ: GLMD
· Real-Time Price · USD
1.43
-0.05 (-3.38%)
At close: Aug 15, 2025, 3:59 PM
1.44
1.05%
After-hours: Aug 15, 2025, 04:00 PM EDT
-3.38% (1D)
| Bid | 1.37 |
| Market Cap | 3.22M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.35M |
| EPS (ttm) | -6.6 |
| PE Ratio (ttm) | -0.22 |
| Forward PE | -1.68 |
| Analyst | n/a |
| Ask | 1.49 |
| Volume | 140,755 |
| Avg. Volume (20D) | 317,166 |
| Open | 1.41 |
| Previous Close | 1.48 |
| Day's Range | 1.41 - 1.47 |
| 52-Week Range | 1.15 - 23.80 |
| Beta | 0.58 |
About GLMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLMD
Website n/a
3 months ago
+10.61%
Galmed Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
10 months ago
-11.93%
Galmed Pharmaceuticals shares are trading lower. The company announced that results of its Phase 3 trial of Aramchol in 150 patients with NASH and fibrosis has been published in Hepatology.
